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Abstract
Background: Genome-wide expression studies have developed exponentially in recent years as a result of extensive 
use of microarray technology. However, expression signals are typically calculated using the assignment of "probesets" 
to genes, without addressing the problem of "gene" definition or proper consideration of the location of the 
measuring probes in the context of the currently known genomes and transcriptomes. Moreover, as our knowledge of 
metazoan genomes improves, the number of both protein-coding and noncoding genes, as well as their associated 
isoforms, continues to increase. Consequently, there is a need for new databases that combine genomic and 
transcriptomic information and provide updated mapping of expression probes to current genomic annotations.
Results: GATExplorer (Genomic and Transcriptomic Explorer) is a database and web platform that integrates a gene 
loci browser with nucleotide level mappings of oligo probes from expression microarrays. It allows interactive 
exploration of gene loci, transcripts and exons of human, mouse and rat genomes, and shows the specific location of 
all mappable Affymetrix microarray probes and their respective expression levels in a broad set of biological samples. 
The web site allows visualization of probes in their genomic context together with any associated protein-coding or 
noncoding transcripts. In the case of all-exon arrays, this provides a means by which the expression of the individual 
exons within a gene can be compared, thereby facilitating the identification and analysis of alternatively spliced exons. 
The application integrates data from four major source databases: Ensembl, RNAdb, Affymetrix and GeneAtlas; and it 
provides the users with a series of files and packages (R CDFs) to analyze particular query expression datasets. The 
maps cover both the widely used Affymetrix GeneChip microarrays based on 3' expression (e.g. human HG U133 series) 
and the all-exon expression microarrays (Gene 1.0 and Exon 1.0).
Conclusions: GATExplorer is an integrated database that combines genomic/transcriptomic visualization with 
nucleotide-level probe mapping. By considering expression at the nucleotide level rather than the gene level, it shows 
that the arrays detect expression signals from entities that most researchers do not contemplate or discriminate. This 
approach provides the means to undertake a higher resolution analysis of microarray data and potentially extract 
considerably more detailed and biologically accurate information from existing and future microarray experiments.
Background
As our knowledge of metazoan genomes and transcrip-
tomes improves, the number of both protein-coding and
noncoding transcripts continues to increase [1,2]. To take
account of the increasing emphasis on transcriptomics,
genomic databases need to be adapted to better accom-
modate this type of data. Consideration of transcriptomic
data necessitates improvements in both the correct map-
ping of all actively transcribed units and the accurate
determination of their expression levels. Ensembl main-
tains and provides visualization of a comprehensive data-
base of all publicly available eukaryotic genome
sequences and contains all major biomolecular entities
(such as RNAs and proteins) with extensive additional
information including mapping of microarray probes [3].
Other databases, such as RNAdb, complement Ensembl
by providing details and annotations of larger collections
of non-coding RNAs (ncRNAs) [4]. However, these bio-
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and they do not provide tools to use up-to-date probe
mapping with query expression datasets. Finally, data-
bases such as GEO include large collections of expression
datasets with powerful analysis tools, but they lack
microarray probe mapping at nucleotide level and pre-
sentation in a genomic context, and instead consider
"probesets" as genes [5]. Several recent transcriptomic
studies are showing that gene loci are considerably more
complex than previously thought, often with networks of
overlapping transcripts on both strands [1], emphasizing
the importance to examine expression data at the nucle-
otide level. Nucleotide level mapping facilitates the iden-
tification of particular probes that uniquely represent the
expression of specific transcripts. It also provides the
possibility to discriminate between alternate isoforms of
the same gene. Such analyses require unambiguous
assignment of the array probes to the functional entities
defined in current transcriptomes (i.e. gene loci, tran-
scripts, exons, ncRNAs), including their specific genomic
location. The huge number of transcriptomic studies
conducted in recent years illustrates the potential
demand for improved analytical approaches of microar-
ray data as well as the opportunity to reinterpret existing
datasets. To provide a means to analyze microarray data
at the nucleotide level in a genomic context we have
developed a database and web platform called GATEx-
plorer. The application integrates information from mul-
tiple biological sources and includes several
bioinformatic tools to allow a novel perspective and inter-
pretation of microarray expression data.
Construction and content
Database integrating genomes, transcriptomic entities and 
expression
To analyze transcriptomic data in a genomic context,
GATExplorer integrates five datasets: (i) the human,
mouse and rat genomes (derived from Ensembl http://
www.ensembl.org); (ii) the sequences and IDs of all oligo-
nucleotide probes (perfect match only) from all Affyme-
trix expression microarrays http://www.affymetrix.com
for these species; (iii) de novo mapping data of each array
probe to the transcriptome of the corresponding organ-
ism, with the genomic coordinates for each locus (includ-
ing locations on exons, introns and across exon-exon
junctions) and identification of any intersecting genes,
transcripts and exons; (iv) mapping data of unmapped
probes to transcripts in RNAdb (research.imb.uq.edu.au/
RNAdb), a database of ncRNAs of human and mouse;
and (v) detailed expression data derived from a set of
microarrays from different cell types, tissues or organs
(GeneAtlas GEO ID GSE1133 [6]) calculated at probe-
and probeset-level using complete de novo mapping.
BLASTN sequence alignment was used to map the 25-
mer oligo probes of the main Affymetrix expression
microarrays to the RNA sequences of human, mouse and
rat, selecting only complete perfect match alignments.
The mapped probes were then placed in the correspond-
ing genome based on the coordinates of the main
genomic entities defined by Ensembl. The versions of the
genomes assemblies and the source databases in current
use are indicated on the website (PROBE MAPPING sec-
tion, "Genomes ASSEMBLY and Databases VERSION").
Each of the source and newly derived datasets are
structured and integrated in a relational SQL database
(MySQL), which can be queried and viewed via the web-
site. For a specified gene locus, the web interface presents
a hierarchical display of the corresponding genomic enti-
ties (chromosome, locus, exons, transcripts and protein
domains), together with detailed mapping of array probes
and probesets and their signal in a set of sample arrays.
This data is presented as follows: (i) Description; (ii)
Chromosome global view (chr [chr number]); (iii) Chro-
mosomal regional view (indicating the specie); (iv) Gene
locus and transcripts view; (v) Expression view (profile in
different tissues); (vi) Probesets table: Affymetrix Probe-
sets which map on [gene locus name]; (vii) Probes table:
Affymetrix Probes which map on [gene locus name].
An illustrative workflow for the general use of GATEx-
plorer is included in the front page of the website to facil-
itate a practical guide of the application. The transcript
and protein sequences within each gene locus are also
provided in a link called "Show SEQUENCES (cDNA)"
included within the "Description" of each gene. Some
other useful links and tools are included in the "Descrip-
tion" box: one external link to the corresponding gene in
Ensembl (indicating the ENSG ID); another external link
to the corresponding proteins associated to this gene in
the Protein Atlas database http://www.proteinatlas.org; a
tool called "Bookmark GENE" that builds a new box
inside the web with direct links to genes selected by the
user: bookmarked genes.
The server can be queried using five access-boxes
located on the left side which receive the following types
of queries: a keyword related to any gene locus; a probe
or probeset ID from Affymetrix; a list of probesets to
find corresponding genes; a sequence (nucleotide or
amino acid) via BLAST; or a range of chromosomal
coordinates. The usage of each of these access tools is
explained in detail in the "Help" section (link on the top
right side of the main page).
Accurate graphical representations of genes, transcripts
and probes in the "Chromosomal regional view" and the
"Gene locus and transcripts view" are achieved using
MING (a library for generating Flash files), which pro-
duces vector drawings in SWF format maintaining the
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sequence length. Interactive links, gene descriptions,
exonic structure and probe positions are included in the
drawings. Each microarray probe is identified by its
sequence, which is included in the "Probes table" together
with its GC content (%). The "Probesets table" and
"Probes table" include links ("Download PROBESETS
(.txt)", "Download PROBES (.txt)") on the top right to
download text files containing the probesets or the
probes that map to the selected gene locus. The complete
mappings for each microarray platform are included in
the PROBE MAPPING section, which is opened in
another browser window (link on the top right side of the
front page of the website).
The PROBE MAPPING section includes several pages
divided into two parts: (i) pages providing the complete
collection of files that can be downloaded by the user to
facilitate the application of the mappings to any particu-
lar microarray dataset that is to be analyzed ("Text Files",
"R Packages" and "Annotation Files"); (ii) pages to explain
how the mapping has been performed and provide data
to compare the results with other methods previously
reported ("Methods", "Statistics", "Comparative Analysis"
and "Genomes & Databases VERSION"). Detailed
descriptions of the downloadable files included in this
section of the database are as follows:
• text files (.txt) with complete unambiguous mapping
of the microarray probesets to genes (probesets2 genes); •
text files (.txt) with complete unambiguous mapping of
array probes to genes (probes2 genes); • text files (.txt)
with complete unambiguous mapping of array probes to
transcripts (probes2transcripts); • text files (.txt) with
complete mapping of microarray probes that are ambigu-
ous because they map on more than one gene locus
(ambigprobes2 genes).
• R chip definition files (CDFs) with complete unambig-
uous mapping of microarray probes to genes (GeneMap-
per); • R chip definition files (CDFs) with complete
unambiguous mapping of array probes to transcripts
(TranscriptMapper); • R chip definition files (CDFs) with
complete unambiguous mapping of array probes to exons
(ExonMapper); • R chip definition files (CDFs) with map-
ping to ncRNAs of the probes that did not map any
known protein-coding exon (ncRNA Mapper).
• annotation files with information about the mapped
entities derived from the Ensembl database: genes
(ENSGs), transcripts (ENSTs) and exons (ENSEs); • anno-
tation files that include only the selected subset of the
protein-coding genes (i.e. the Ensembl gene loci, ENSGs,
that correspond to mRNAs) or the selected subsets of
known microRNAs (i.e. the Ensembl gene loci that have
been assigned to microRNAs).
The PROBE MAPPING section also presents details
regarding the specific "Methods" used, the "Statistics"
regarding the mapping to different transcribed entities
and a "Comparative Analysis" with other related applica-
tions. The "Methods" page provides descriptions and
links to the main data sources used in GATExplorer and a
graphical schematic view of the pipeline followed to build
the web platform, presenting the main steps and proce-
dures applied and the files and packages provided by the
server. The "Statistics" page provides the data derived
from the sequence mapping of all the oligonucleotide
probes from Affymetrix expression microarrays into dif-
ferent types of RNAs. Probes are classified as mapping to:
protein-coding RNAs (mature mRNAs), non protein-
coding RNAs (ncRNAs) or unassigned to any known
RNA (NA). Probes that only map to introns were classi-
fied as mapping to putative ncRNAs. The percentage of
probes mapping to each class is provided for four types of
widely used human expression microarrays platforms.
The page also provides statistics on the number and per-
centages of transcripts and genes mapped by the probes
in each Affymetrix expression microarray (for human
Homo sapiens, mouse Mus musculus and rat Rattus nor-
vegicus); and the number and percentages of probes that
map to transcripts and genes with respect to the total in
each array. The "Comparative Analysis" page includes a
comparison of GATExplorer with other related applica-
tions that have been previously published. The page
examines four studies that have undertaken an alternative
mapping of probes to genes for Affymetrix microarrays.
Some of these re-mapping approaches and tools are lim-
ited to a subset of microarray platforms or do not apply to
whole-transcript expression microarrays (i.e. Gene 1.0
and Exon 1.0). Among the previous studies, none present
mapping to intronic regions or ncRNAs.
Figure 1 presents a graphical view of the main data
sources and methods included in GATExplorer described
above. The graph shows the pipeline followed to build the
database and web platform. The probe mapping files
(Text files) and packages (R CDFs) are freely provided as
part of the repository to allow researchers to use the
microarray probe remapping data for their own expres-
sion analyses.
Each gene can be queried to find detailed information
on the mapping of probes to their corresponding locus,
transcripts and exons. When a gene loci is shown in the
associated GATExplorer web page, the "Gene locus and
transcripts view" presents all the probes that map to such
loci for each of the Affymetrix microarrays. As mentioned
above, the information about such probes indicating
whether they are ambiguous (i.e. multi-mapping) or not
is included in the table called "Probes table". After map-
ping, each probe is designated with a COLOR CODE
(green, yellow, red and black) to indicate whether it is
ambiguous or not (see HELP section). As a result, all
ambiguous probes that can cross-hybridize with several
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Figure 1 Graphical view of the pipeline followed to build the GATExplorer application, showing the data sources integrated (Ensembl, 
RNAdb, Affymetrix and GeneAtlas -i.e. the four external databases marked in blue square frames-) and a schematic view of the main meth-
ods applied at each step -marked with grey gears. As a result, the outputs from the pipeline provide the web platform, which encloses several 
inhouse built databases -marked in yellow square frames- and several data and tools -marked in orange-, including the files (Text files) and packages 
(R CDFs) with the de novo mapping of the array probes to the transcriptome of the corresponding organism (human, mouse or rat). The application 
also provides the genomic coordinates to each locus (including mapping on exons, introns and along exon-exon junctions) and identification of any 
intersecting genes, transcripts, exons and ncRNAs.
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identified. The probes that are transcript-specific or
exon-specific are provided in a link ("Probes ... specific"
link) to another page that includes the list of correspond-
ing Ensembl ENST or ENSE IDs. The "Expression view"
provides the expression profile of the queried gene in a
set of different organs, tissues or cell types (Su et al. 2004
dataset [6]) and shows the expression signal per probe for
each of the probes assigned to this gene locus or the
global expression signal as log2 of the mean of all probes.
We provide an example to facilitate the use of the
described views and tools included in GATExplorer:
human gene MEST (mesoderm-specific transcript
homolog genes, Ensembl ENSG00000106484). This gene
is located on chromosome 7 and its locus is 20.08 Kbp
long. It has 4 transcripts and 16 exons. It is mapped by
175 distinct Affymetrix probes, which are included
amonst 9 different microarray platforms. In the case of
array HGU133 plus 2, 11 probes map to this gene, which
correspond to Affymetrix probeset 202016_at. This
probeset does not include any "transcript-specific probe"
because all probes map to the 4 known transcripts. For
this gene the highest expression measured corresponds to
bone marrow samples.
Utility and discussion
Mapping genes, transcripts and exons: coverage and 
efficiency
Accurate expression determination requires that
microarray probes have minimal cross-hybridization with
other genes or other transcribed entities. The GATEx-
plorer database includes detailed information regarding
the coverage and efficiency of the probe mapping (Tables
1, 2). Coverage is defined as the proportion (i.e. %) of gene
loci or transcripts from the total genes/transcripts of the
Ensembl genomes (human, mouse or rat) that are
mapped by the probes of a given microarray. Efficiency is
defined as the proportion (%) of probes from the total
probes of a given microarray that map to Ensembl genes
or transcripts. The term "unique mapped" refers to those
gene loci or transcripts that are targeted by a set of probes
of a given microarray that do not cross-hybridize (i.e.
map unambiguously) with any other known gene loci or
transcript.
The quantity and percentage of human gene loci and
transcripts targeted by the most widely used human
Affymetrix expression microarrays based on 3' expression
(U133A and U133 Plus 2.0) and the new all-exon arrays
(Gene 1.0 and Exon 1.0) is summarized in Table 1. The
data shows that the Gene 1.0 and Exon 1.0 arrays achieve
the highest coverage over gene loci: 82.57% and 95.82%,
respectively (mapping to a total of 27184 human genes,
obtained from genome assembly Ensembl v53 NCBI36).
Such coverage (which depends on the quality of the
genome annotation) has improved with respect to previ-
ous array models; for example, U133A shows 55.36% cov-
erage of the current Ensembl genes. The transcript
coverage also improves in the newer models (mapping to
a total of 53024 human transcripts, obtained from the
same genome assembly). However, the coverage
decreases when "unique mapped" genes or transcripts are
considered. For example, in the case of the human Gene
1.0 array, 73.29% of the genes are mapped by unique sets
of probes. In any case, the overall coverage to measure
expression from most human gene loci has improved by
27%, from U133A (55%) to Gene 1.0 (82%).
With respect to the efficiency of the probe mapping,
Table 2 presents the number and percentage of distinct
probes in each microarray (i.e. probes of distinct
sequence) that map to one or more transcripts or gene
loci, for the most commonly used human microarray
models. Therefore, the columns with >1 include the
probes that map to more than one transcript or gene
locus. Those probes that map to several transcripts or
loci, can be considered "ambiguous" probes. The figures
show that the best mapping efficiency (88.41%) is
obtained with the Gene 1.0 array. For the U133A array,
78.86% of the probes map to known gene loci of the cur-
rent human genome version (Ensembl v53 NCBI36). The
mapping efficiency decreases even further, to 74.5%
(180188/241898), when only probes that hybridize to one
gene locus are considered (e.g. 180188 probes for
U133A). Therefore, probe mappings to human cDNA
show that a significant portion (5.54% for U133A and
7.44% for Gene 1.0) hybridize "ambiguously" to more
than one gene locus. A larger percentage of probes
(55.40% for U133A and 45.55% for Gene 1.0) can hybrid-
ize to more than one transcript. Therefore, only a certain
percentage of probes can be regarded as gene-specific or
transcript-specific. As a general conclusion, these calcu-
lations indicate that a significant proportion of probes
(about 20 to 25% when mapping genes with U133A) can
produce noise using standard expression signal calcula-
tions based on the probesets assigned by Affymetrix.
The described problem is also present in the new Exon
1.0 arrays, which show the lowest efficiency with only
25.5% of the probes mapping to known genes. This
apparently low efficiency is not contradictory with a
newly manufactured array, because the Exon 1.0 arrays
have been designed with a different goal to previous gene
expression arrays, which was not just to cover known
genes, but to be able to distinguish the expression of each
exon in a given locus. To achieve this goal, the array
includes a complex collection of exon probes that corre-
spond to five types of probesets based on different
degrees of evidence: core, extended, full, ambiguous and
free. Descriptions of each of these probesets can be found
in the Affymetrix white paper on the Exon arrays (called
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from the Affymetrix website http://www.affymetrix.com/
support/help/exon_glossary. The most important probe-
sets correspond to the "core" type, which are the ones
supported by the most reliable evidence from RefSeq and
full-length mRNA GenBank records containing complete
CDS information (see exon_array_design_technote.pdf).
Recent analytical tools for the Exon 1.0 arrays recom-
mend use of just the "core" set [7]. In the case of human
Exon 1.0, the "core" set is composed of 1,082,385 probes
http://www.aroma-project.org/chipTypes/ and these
probes are mostly included in the set of 1,252,500 probes
that GATExplorer assigns to mRNAs exons for this array
(see Figure 2). These numbers show that the probe
remapping data used in GATExplorer allows the use of a
larger set of probes than the "core" set described by
Affymetrix.
The analysis of coverage and efficiency presented in
Tables 1 and 2 should be considered together with the
analysis presented in Figure 2, which includes informa-
tion about the mapping and assignment of all probes
from different arrays to protein-coding genes and to ncR-
NAs (derived from Ensembl and from RNAdb). The first
part, corresponding to the assignment to mRNAs, is
marked in green in the pie graphs in Figure 2. These
green sectors indicate the proportion of probes that map
to known genes, which are large in the case of expression
arrays specially designed to measure genes, as human
U133A and Gene 1.0 with green sectors of 78.0% and
71.8%, respectively. The blue sector corresponds to ncR-
NAs, which is exclusively provided by the GATExplorer
database. In this sector, we have included those probes
that map within "introns" because these probes may mea-
sure signal from putative exons included in alternative
mRNAs. Indeed, the proportion of probes mapping in
such putative or hypothetical exons is comparatively large
in the exon arrays (1,352,630 probes of human Exon 1.0),
showing that this array is designed to measure many
alternative mRNAs. As indicated above, the exon arrays
are not only designed to detect mRNAs and for this rea-
son they include many other probes apparently not
assigned to any RNA (NA, red sector in pie graphs).
Some of these probes correspond to oligos designed for
the exon boundaries or for the UTR 3' and 5' borders.
Many of these probes map to non-genic regions with little
evidence to support their transcription. However, it has
been reported that the UTR regions of many human and
mouse genes are not well defined, so expression of some
of these probes would be anticipated [8]. Nevertheless
most of the probes on the human Exon 1.0 array are out-
side of the "core" reliable set. Complete information and
statistics regarding the coverage and efficiency of each
microarray platform from human, mouse and rat are
included in the GATExplorer database in the PROBE
MAPPING section.
Comparison of the use of genes versus probesets in 
expression calculations
In the expression profiles provided by the GEO database
and in the many associated publications http://
www.ncbi.nlm.nih.gov/geo, the most common approach
to calculate gene expression signals is using the Affyme-
Table 1: Coverage of the probe mapping.
Transcripts Gene Loci TOTAL N of 
Transcripts
TOTAL N of 
Gene Loci
Unique mapped All mapped Unique mapped All mapped
N
transcripts
% N
transcripts
% N gene loci % N gene loci %
Microarray
HG U133A 7198 13,57% 31219 58,88% 12218 44,95% 15048 55,36% 53024 27184
HG U133 
Plus 2.0
11755 22,17% 42819 80,75% 17710 65,15% 20764 76,38% 53024 27184
Human 
Gene 1.0
19947 37,62% 48169 90,84% 19923 73,29% 22446 82,57% 53024 27184
Human 
Exon 1.0
28024 52,85% 51851 97,79% 23967 88,17% 26047 95,82% 53024 27184
Coverage of the probe mapping for four human Affymetrix microarray models: U133A, U133 Plus 2.0, Gene 1.0 and Exon 1.0. Coverage is defined as 
the proportion of gene loci or transcripts from the total genes/transcripts of the Ensembl human genome that are mapped by the probes of a given 
microarray. The term "unique mapped" indicates the gene loci or transcripts mapped by a unique set of probes of a given array that do not cross-
hybridize with any other known gene loci or transcript (i.e. such probes are not ambiguous). N corresponds to number of gene loci or transcripts.
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ing assumptions carry considerable risks and there are
few comparative expression studies that investigate the
value of using up-to-date mapping of probes to genes,
although it has been reported that this approach
improves the precision and accuracy of microarrays [9].
Therefore, to investigate how the application of the
remapping may affect the expression data, we present in
Figure 3 the results of a comparative study of several
microarray datasets that were analyzed either using the
standard Chip Definition Files (CDFs) to "probeset" or
using the new Chip Definition Files (CDFs) that include
the "gene-specific" remapping and assignment, provided
by GATExplorer. These analyses are performed using
first three different expression signal calculation algo-
rithms (MAS5.0, FARMS and RMA) with CDFs to
"probesets" and then using RMA with CDFs to "genes"
(i.e. using the GeneMapper packages) [10-12]. These
three algorithms are well-known (Affycomp website affy-
comp.biostat.jhsph.edu) and RMA is nowadays the most
widely used to calculate microarray gene expression sig-
nals [13,14]. Following the application of the expression
calculation algorithms with different CDFs, a common
robust algorithm for differential expression called SAM
was applied to all the data [15]. All the analyses were per-
formed using R and the BioConductor packages (see web-
site: http://www.bioconductor.org/).
The datasets are a collection of mouse microarray
experiments (including four different Affymetrix plat-
forms) corresponding to five sets of six samples. Each set
includes three biological replicates of knock-out (KO)
mice for a specific gene that are compared to three bio-
logical replicates of the corresponding wild-type (WT)
mice. The five gene KOs are: APOE-/-, IRS2-/-, NRAS-/-,
SCD1-/- and ENG+/-. The full name of these genes, the
Ensembl ID number (ENSG) and the probesets assigned
by Affymetrix are indicated in Figure 3. Three genes have
a unique Affymetrix probeset (APOE, IRS2 and ENG)
and two genes have two probesets (NRAS and SCD1).
The main feature to be evaluated in the comparison is:
how the mapping with the CDFs to "probesets" and the
mapping with the CDFs to "genes" affect the detection of
the KO genes. In optimum conditions, the gene that is
not present in the KO mice should suffer one of the most
dramatic differences when compared with the WT and
show a significant "repression" or "down-regulation". A
priori we do not know how many other genes can be
affected by the KO gene and we do not know the overall
biological/functional signature associated to each KO
gene. For this reason, we do not assume that the KO gene
will always be the most repressed.
The data and statistical parameters calculated in the
comparison, shown in Figure 3, are: (1) full name of the
gene, corresponding probesets assigned by Affymetrix
and Ensembl ENSG ID number; (2) rank of the KO gene
across down-regulated genes; (3) rank of the KO gene
across all genes; (4) p-value from SAM for the KO gene;
(5) d-value from SAM for the KO gene; (6) number of
significant genes with q-value < 0.10 (using the assign-
ment of probesets to genes provided either by Affymetrix
Table 2: Efficiency of the probe mapping.
Transcripts Gene Loci TOTAL N 
of probes 
mapped
TOTAL N of 
probes in 
the 
microarray
Mapping 
efficiency
1 >1 1 >1
N probes % N probes % N probes % N probes %
Microarray
HG U133A 85075 44,60% 105677 55,40% 180188 94,46% 10564 5,54% 190752 241898 78,86%
HG U133 
Plus 2.0
150060 47,74% 164260 52,26% 299482 95,28% 14838 4,72% 314320 594532 52,87%
Human 
Gene 1.0
387229 54,45% 323912 45,55% 658258 92,56% 52883 7,44% 711141 804372 88,41%
Human 
Exon 1.0
614549 45,75% 728669 54,25% 1263553 94,07% 79665 5,93% 1343218 5270588 25,49%
Efficiency of the probe mapping for four human Affymetrix microarray models: U133A, U133 Plus 2.0, Gene 1.0 and Exon 1.0. Efficiency is defined as 
the proportion of probes from the total probes of a given microarray that map to Ensembl human genes or transcripts. N corresponds to number 
of probes.
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assigned within the microarray; (8) percentage of signifi-
cant genes with respect to the total.
The highest ranked statistical value among the four
comparisons is highlighted in yellow (although, it is
important to note that the highest statistical rank does
not imply the most biologically relevant change). In four
out of five cases (IRS2, NRAS, SCD1 and ENG) the newly
calculated gene mapping provides a better rank than the
standard mapping, according to the statistical signifi-
cance of the differential expression of the KO gene. The
number of genes with q-value < 0.10 (which indicates the
extension of the significant change) was the largest with
the newly calculated gene mapping for two KO genes:
APOE, 9.29% changed genes; NRAS, 0.28% changed
genes. Finally, the p-value of the statistical test was lowest
with the new mapping for KO genes ENG and IRS2. The
results consistently indicate that the method using CDFs
with the new remapping to "genes" provides at least as
significant changes as the best of the three methods based
on Affymetrix "probesets" CDFs.
We emphasize that the purpose of these analyses is not
to propose a new algorithm, but rather to determine in a
comparative approach whether the array probe remap-
pings provide results that are at least of equal quality to
the original probesets. A complete evaluation of the
methods will need a deep biological and functional analy-
sis of the results that goes beyond the scope of this paper.
To facilitate further analysis and independent compari-
son, we provide in the website the raw datasets (CEL files)
corresponding to the results presented in Figure 3. More-
over, APOE, NRAS and SCD1 microarray samples can be
downloaded in GEO database: GSE2372, GSE14829 and
GSE2926, respectively http://www.ncbi.nlm.nih.gov/geo.
Remapping expression probes to ncRNAs
As indicated above, the proportion of probes on the
human arrays that map to genes was 78.9% for U133A,
52.9% for U133 Plus 2.0 and 25.5% for Exon 1.0. This effi-
ciency is fractionally lower when only "protein-coding
gene loci" (i.e. loci that encode mRNAs translated to pro-
teins) are considered: 78.0% for U133A, 52.3% for U133
Plus 2.0 and 23.8% for Exon 1.0 arrays. This shows that a
large fraction of probes within these microarrays do not
map to any known protein-coding RNA (i.e. mRNA).
Therefore, we performed a remapping of those probes
not assigned to mRNAs to a database of ncRNA
sequences (RNAdb v.1 from 2009) [4]. These ncRNAs
belong to the mRNA-like class of long ncRNAs. These
were predominantly identified in cDNA libraries, such as
those used in the FANTOM3 and H-Invitational datasets
[1,16]. Because cDNA library generation typically
involves poly-dT priming, such cDNA sequences largely
arise from polyadenylated transcripts. However, due to
the possibility of internal priming from polyA-rich tracts,
some non-polyadenylated transcripts may also be pres-
ent. Nevertheless, such transcripts are represented in any
gene expression study that employs a microarray protocol
that selectively amplifies polyadenylated transcripts by
poly-dT priming. The new generation Affymetrix
microarrays Gene 1.0 and Exon 1.0 use WT random
primed amplification, which does not necessitate the
Figure 2 Table and pie graphs summarizing the probe mapping from four widely used human Affymetrix microarray models (U133A, U133 
Plus 2.0, Gene 1.0 and Exon 1.0) to different transcribed entities. The figure includes information about the mapping and assignment of probes 
considering tree types: (i) green, probes mapped to translated genes (mRNAs, i.e. exons encoding for proteins); (ii) blue, probes mapped to ncRNAs 
(derived from RNAdb and from genes labeled as non-protein-coding in Ensembl); (iii) red, probes not mapped to any known RNA (NA, not assigned).
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detect many more ncRNAs.
The results of the remapping of array probes to ncR-
NAs showed that 29.7% of the probes from human Exon
1.0 and 26.5% of the probes from U133 Plus 2.0 map to
ncRNAs. A summary of this remapping is presented in
Figure 2, which shows the percentages of probes that map
to ncRNAs, combining both the information from
RNAdb and from genes labeled as non-protein-coding in
Figure 3 Comparison of the differential expression calculated by the SAM algorithm for a series of data of mouse microarrays (five sets of 
six samples) analyzed using three different expression signal calculation algorithms (MAS5.0, FARMS and RMA) with standard CDFs to 
"probesets" or using RMA with CDFs to "genes" (GeneMapper CDFs). Each set includes three biological replicates of knock-out (KO) mice for a 
specific gene compared to three replicates of the corresponding wild-type (WT) mice. The gene KOs are: APOE-/-, IRS2-/-, NRAS-/-, SCD1-/- and ENG+/
-. The full name of these genes, the Ensembl ID number (ENSG) and the probesets assigned by Affymetrix are indicated in the top line of each set, la-
belled Entry (1). The table shows the numbers for the statistical parameters calculated in the comparison, which are: (2) rank of the KO gene across 
down-regulated genes; (3) rank of the KO gene across all genes; (4) p-value from SAM for the KO gene; (5) d-value from SAM for the KO gene; (6) 
number of significant gene loci with q-value < 0.10 (this calculation was performed such that all probesets were assigned to specific genes following 
the Affymetrix assignment or the GeneMapper assignment; therefore the methods are comparable since the number of gene loci indicated are the 
fraction of total mouse genes assigned); (7) total number of mouse gene loci assigned within the microarray; (8) percentage of significant gene loci 
with respect to the total. Yellow background indicates the top values for each statistical parameter calculated with each of the four procedures used. 
The comparison that includes the identical methods for expression calculation (RMA) and for differential expression (SAM) changing only the CDFs 
is presented in the last two columns, framed with a black line.
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map within introns.
Expression of ncRNAs is becoming of increasing inter-
est due to the accumulating evidence showing that ncR-
NAs are biologically relevant. A key question in
investigating ncRNA function is determining whether
ncRNAs produce distinct expression signals or just
reflect background "noise". To check the variability and
detectability of changes in expression provided by the
ncRNAs, we selected the 92,094 probes from the U133
Plus 2.0 array that map to ncRNAs according to our map-
ping to RNAdb (see Figure 2). This set of probes is pro-
vided in the CDF package "ncRNA Mapper" (file
ncrnamapperhgu133plus2cdf_1.0). This CDF file was
applied to a microarray dataset obtained from GEO
(GSE3526), which includes 353 arrays corresponding to
samples from 65 different normal human tissues. The
expression of the ncRNAs assigned by the CDF package
was calculated using the RMA algorithm. Following the
calculation of the expression signals, we determined the
number of ncRNAs showing significant differential
expression by performing a statistical analysis of variance
using an anova test (function aov from stats R package).
This analysis indicated that 70.5% of the assigned ncR-
NAs showed differential expression with p-values < 0.01
(p-values corrected by Bonferroni method). This means
that 4,274 ncRNAs (out of 6,062) changed in all replicates
in at least one set of tissues. These results reveal the
importance of considering expression signals coming
from ncRNAs in transcriptomic studies. Moreover, there
is an increasing number of reports showing the biological
importance of new transcribed entities that do not
encode for proteins, and demonstrate that many play
important and diverse roles in cellular function [17,18].
Conclusions
Beyond the "gene" in microarray studies
Genome-wide expression studies have developed expo-
nentially in recent years due to the use of microarray
technology [5]. Presently, the most reproducible and
widely used microarrays are high-density oligonucleotide
microarrays, which feature synthetic oligos based on
cDNA and EST sequences. New high-throughput RNA-
sequencing will become an excellent complement to
microarray datasets, providing highly detailed informa-
tion about all transcribed entities [19]. However, due to
the large number of studies performed with expression
microarrays (both past and present) it remains worth-
while to improve the manner by which these data are ana-
lyzed. The specific assignment of array probes to current
gene annotations, transcripts and exons and the provi-
sion of tools to visualize array expression signals in an
updated genomic context represent a significant
enhancement to currently available methods. With the
continued erosion of traditional definitions of "gene"
being exposed through transcriptomic sequence data
[20,21], as well as the increasing importance of ncRNAs
in understanding disease and development [17], the data
and analytical techniques enabled by GATExplorer com-
prise an important aspect for the meaningful interpreta-
tion of microarray expression information and its
integration within the transcriptome.
The first attempt to provide alternative mapping of
Affymetrix microarray probes to the latest versions of
human genes was reported by Gautier et al. in 2004 [22].
Since this report, several studies have been published
providing redefinitions of Affymetrix microarray probe
and probesets to genes and transcripts, including tools to
use such redefinitions [22-29]. Dai et al. developed prob-
ably the most comprehensive mapping of microarray
probes from several species [23]. Despite the reannota-
tion of Affymetrix microarray probes and probesets to
genes and transcripts having been reported previously,
GATExplorer is the first system that integrates mapping
of probes (including maps to ncRNAs) with simple
genomic contextual views, as well as expression signals at
probe level. A study and comparison of the characteris-
tics of five major applications that have undertaken an
alternative mapping of probes to genes for Affymetrix
microarrays can be seen in the "Comparative Analysis"
page of the PROBE MAPPING section of GATExplorer
(the comparison corresponds to references [22-24,28]
and this work).
Regarding the visualization of the probes in a genomic
context, current genome browsers (such as the UCSC
browser: http://genome.ucsc.edu/, and Ensembl browser:
http://www.ensembl.org) incorporate large amounts of
data with complex genome-wide information, including
location of the probesets from microarrays. Other web
sites, like X:map, provide specific annotation and visual-
ization of Affymetrix exon arrays probesets and probes
within the genome structure [30]. Exon Array Analyzer is
a web tool that allows analysis of exon arrays to detect dif-
ferentially expressed exons and places the probes within
the corresponding genes [31]. The open-source software
BioConductor (http://www.bioconductor.org/), includes a
package called GenomeGraphs to plot genomic informa-
tion from Ensembl, which uses biomaRt to query the
genomes database and transform gene/transcript struc-
tures to graphical views, with the possibility of including
probes from exon arrays. Affymetrix has also developed
an application for visualization and exploration of genes,
genomes and genome-scale data sets, called Integrated
Genome Browser (IGB) that uses the GenoViz and
Genometry software (http://genoviz.sourceforge.net/).
Although these applications are useful, they fulfil
demands that differ to that of GATExplorer. The impor-
tance of the work presented here lies in the demonstra-
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Page 11 of 12tion of the large proportion of probe targets that
microarrays detect which most researchers do not con-
sider in an expression experiment, and to allow them to
use the expression signals arising from non-coding RNAs
and hypothetical exons.
In conclusion, GATExplorer is an integrated database
and web platform that is useful to visualize, analyze and
explore the increasing complexity of eukaryotic tran-
scriptomes (human, mouse and rat), which includes
microarray probes mapping to gene loci, transcripts and
exons (even exon-exon junctions), as well as introns and
ncRNAs.
Availability and requirements
The database is available at http://bioinfow.dep.usal.es/
xgate/. GATExplorer is open access and the website
makes available all the files and packages described here.
The website also includes a "Help" section to facilitate the
use of the application.
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